Original Research
Accepted on 16 Jul 2025
Combined treatment with CDK4/6, CDK2, and CXCR1/2 inhibitors effectively halt the growth of BRAF wild-type melanoma tumors
in Cancer Molecular Targets and Therapeutics
Original Research
Accepted on 16 Jul 2025
in Cancer Molecular Targets and Therapeutics
Review
Accepted on 16 Jul 2025
in Cancer Molecular Targets and Therapeutics
Case Report
Accepted on 16 Jul 2025
in Dermatology
Original Research
Accepted on 16 Jul 2025
in Machine Learning and Artificial Intelligence
Case Report
Accepted on 16 Jul 2025
in Clinical Diabetes
Mini Review
Accepted on 16 Jul 2025
in Sustainable Food Processing
Editorial
Accepted on 16 Jul 2025
in Pulmonary Medicine
Original Research
Accepted on 16 Jul 2025
in Urban Economics
Original Research
Accepted on 16 Jul 2025
in Pulmonary Medicine
Original Research
Accepted on 16 Jul 2025
in Modeling and Optimization for Decision Support
Opinion
Accepted on 16 Jul 2025
in Blue Food Provisions
Original Research
Accepted on 16 Jul 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 16 Jul 2025
in Colorectal and Proctological Surgery
Original Research
Accepted on 16 Jul 2025
in Engine and Automotive Engineering
Original Research
Accepted on 16 Jul 2025
in Plant Pathogen Interactions
Original Research
Accepted on 16 Jul 2025
in Crop and Product Physiology